Same-Visit Contraception: Implementation Strategies from the FieldJSI
According to the CDC and OPA, clients should have access to their contraceptive method of choice without unnecessary delays. Same-visit provision of contraception means providing immediate access to contraceptive methods using Quick Start. As long as a clinician can be reasonably certain a client is not pregnant, there is not medical reason to require clients to return for a follow-up visit or to initiate methods during menses. Clients face many barriers (work, child care, secure transportation) when asked to return for a second visit in order to initiate contraception and up to 50% of clients will not return for a follow up appointment.
Title X grantees and service sites across the country to identify successful strategies for implementing same-visit contraception including: 1. Stock devices and make supplies readily available, 2. Adjust systems for efficient and sustainable service delivery, 3. Engage, train, and support all staff.
To support implementation to Title X service sites, the FPNTC provides a Same-Visit Contraception Guide which includes: video case studies, slides and a discussion guide, interactive tools including checklists, calculators and printable sheets that can be posted at the office.
Presentation by Carmel O'Brien, Chief Nurse and Quality Officer at East Leicestershire and Rutland Clinical Commissioning Group to the Patient and Public Engagement Group on 15th July 2015
Ayo Akinrinmade, Information Scientist at Orphanet, spoke in the 'Current initiatives in rare diseases' panel at the Cambridge Rare Disease Summit 2015.
Same-Visit Contraception: Implementation Strategies from the FieldJSI
According to the CDC and OPA, clients should have access to their contraceptive method of choice without unnecessary delays. Same-visit provision of contraception means providing immediate access to contraceptive methods using Quick Start. As long as a clinician can be reasonably certain a client is not pregnant, there is not medical reason to require clients to return for a follow-up visit or to initiate methods during menses. Clients face many barriers (work, child care, secure transportation) when asked to return for a second visit in order to initiate contraception and up to 50% of clients will not return for a follow up appointment.
Title X grantees and service sites across the country to identify successful strategies for implementing same-visit contraception including: 1. Stock devices and make supplies readily available, 2. Adjust systems for efficient and sustainable service delivery, 3. Engage, train, and support all staff.
To support implementation to Title X service sites, the FPNTC provides a Same-Visit Contraception Guide which includes: video case studies, slides and a discussion guide, interactive tools including checklists, calculators and printable sheets that can be posted at the office.
Presentation by Carmel O'Brien, Chief Nurse and Quality Officer at East Leicestershire and Rutland Clinical Commissioning Group to the Patient and Public Engagement Group on 15th July 2015
Ayo Akinrinmade, Information Scientist at Orphanet, spoke in the 'Current initiatives in rare diseases' panel at the Cambridge Rare Disease Summit 2015.
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
Hassan introduces the concept and key objectives of transfer of care to pharmacy (TCP). The slides include a project outline, an overview of TCP in Cheshire and Merseyside, and the benefits and potential savings of Electronic Transfer of Care to Pharmacy.
3.4 Measuring access - Mitchell Briggs, Louise Harvey, Brian NivenNHS England
Measuring access. Measuring access in general practice. Focusing on the GP Access Fund national evaluation, the bi-annual data collection and the general practice workload tool. Mitchell Briggs, Programme Lead, Improving Access to General Practice, NHS England; Louise Harvey, Stakeholder Engagement Lead, Improving Access to General Practice, NHS England, Brian Niven, Technical Director, Mott Macdonald.
1.3 Develop the team - pharmacists - Ravi SharmaNHS England
Develop the team - pharmacists. Using clinical pharmacists as part of the practice team. Featuring experience from the national clinical pharmacists programme. Ravi Sharma, clinical lead for NHS England's clinical pharmacy programme.
Drug, big-box and grocery stores are providing patient management for people with chronic diseases, vaccinations, screenings and medical care — all once the domain of doctors and hospitals. And they’re providing these services at times convenient to consumers and often at lower prices, two things sought-after by today’s time-strapped and price-conscious consumers with high deductible health plans who are shopping for care as never before. This rivalry between nontraditional providers, innovative health care companies and established health care institutions is transforming health care and access to health services. Hear how to successfully compete in the new health economy.
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
Hassan introduces the concept and key objectives of transfer of care to pharmacy (TCP). The slides include a project outline, an overview of TCP in Cheshire and Merseyside, and the benefits and potential savings of Electronic Transfer of Care to Pharmacy.
3.4 Measuring access - Mitchell Briggs, Louise Harvey, Brian NivenNHS England
Measuring access. Measuring access in general practice. Focusing on the GP Access Fund national evaluation, the bi-annual data collection and the general practice workload tool. Mitchell Briggs, Programme Lead, Improving Access to General Practice, NHS England; Louise Harvey, Stakeholder Engagement Lead, Improving Access to General Practice, NHS England, Brian Niven, Technical Director, Mott Macdonald.
1.3 Develop the team - pharmacists - Ravi SharmaNHS England
Develop the team - pharmacists. Using clinical pharmacists as part of the practice team. Featuring experience from the national clinical pharmacists programme. Ravi Sharma, clinical lead for NHS England's clinical pharmacy programme.
Drug, big-box and grocery stores are providing patient management for people with chronic diseases, vaccinations, screenings and medical care — all once the domain of doctors and hospitals. And they’re providing these services at times convenient to consumers and often at lower prices, two things sought-after by today’s time-strapped and price-conscious consumers with high deductible health plans who are shopping for care as never before. This rivalry between nontraditional providers, innovative health care companies and established health care institutions is transforming health care and access to health services. Hear how to successfully compete in the new health economy.
Virdatint Distributed Data Virtualization Basics_2.6Virdatint
Virdatint’s unique comprehensive Distributed Data Virtualization, Integration, Analytics and Security platform, bridges the gap between customer-facing operational systems and MDM, CRM, BPM, BI and analytics in near real-time, to grow revenue and decrease costs. Because it leverages existing architectures and systems, leaves data in-place, and offers a unique approach to indexing, link mapping and analysis, implementation is rapid and the resulting operational costs are low.
For the Nuffield Trust Health Policy Summit, Stephen Shortt tells the story of a journey from multiple unconnected practices to accountable community based integrated services at scale.
Preparing for the Board Assurance framework for 7DS with guest speaker from U...NHS England
This webinar will provide:
• An update on the requirements of the new Board Assurance Framework for 7 day services
• An opportunity to hear the experience of University Hospitals Plymouth NHS Trust which was one of the pilot sites
• An opportunity to raise queries and share learning
Slides from the Strategic Clinical Network, Cardiovascular Disease Network meeting on 16 January 2015.
The event was run by the Living Longer Lives programme and covers the work we’re doing to implement the Department of Health’s CVD Outcomes strategy, including improving the physical health of people with serious mental illness, supporting the NHS Health Check programme and the GRASP suite of audit tools.
7DS Board Assurance Framework: Planning or June 2019 submissionNHS England
This webinar will provide:
• Key lessons learned from review of 7DS Board Assurance Framework (BAF) return in February
• Information on how to prepare for the next submission by 28th June 2019
• An opportunity to raise questions
Adult survivorship: from concept to innovationNHS Improvement
The National Cancer Survivorship Initiative (NCSI) is a partnership between the Department of Health, Macmillan Cancer Support and NHS Improvement. As part of this initiative, NHS Improvement is testing approaches to care and support that ensures that we are moving to a position of not only supporting recovery from their disease, but also their future health and wellbeing through sustaining that recovery. During the last few years a proof of principle has been established which if transferable from the test sites to other organisations will begin the process of spread across the NHS and provide national risk stratified effective pathways for breast, colorectal and prostate cancers.
Making Seven Day Services a reality, pop up uni, 2 pm, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Edifecs: Demonstrating who you are in CJREdifecs Inc
A hands-on approaches for hospitals to strategically align orthopedic surgeons and post-acute providers under CJR. This Presentation focuses on tools that providers can use to help manage their performance to be successful under the new value-based environment.
Similar to NHS Eastern Cheshire CCG Deepdive presentation GBAF17 (20)
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
1. Deep Dive GBAF17 Risk:
Elective, Diagnostic and Outpatient Access to
Services
Sally Rogers
Executive Nurse and Quality Director (interim)
27 July 2016
2. Current Performance vs National requirement
Recent reports indicate that, under the NHS Constitution, the CCG is unable to
meet its statutory duty to provide patients with timely access to treatment in
some specialities across its providers¹:
• 18 weeks RTT – 91.5% vs. 92% patients seen within 18 weeks including ENT,
gastroenterology, trauma & orthopaedics, vascular surgery, urology, gynaecology,
plastic surgery which commonly are the areas where cancellations occur when
hospitals are under pressure
• Cancer Waits – 2 weeks waits achieving at 99% vs. 93%
62 day waits fluctuates 76.5% vs. 85% and 62 day screening 66.7% vs 90%
• A & E 4 Hour Wait – Not achieving 83.57% vs. 95% patients being seen. Similar
situation with all other local acute providers
• Diagnostics – achieving
¹NHSE Cheshire & Merseyside Provider Performance – May 2016
3. Summary of key actions taken
• Any Qualified Provider (AQP) process in order to secure more capacity
• Additional patient capacity was secured for; Ophthalmology, Elective Surgery
and Gastroenterology
• The CCG undertook a redesign of access criteria to direct patients to appropriate
services to support access and improve safety
• Risk first reported November 2015
• Risk reduced in March 2016 following AQP process
• Request that the risk level be raised due to continued high numbers of
referrals still going to East Cheshire NHS Trust where capacity exists
elsewhere
4. Summary of new actions to be taken
• Work with and support Primary Care to increase the number of e-Referrals
• Work with Primary Care to support patients to use the e-Referral system (eRs)
and make informed choices
• Work with ECT to increase the number of existing specialities to be included on
the eRs
• Undertake a review of the CCG Commissioning Policy Criteria 2014/15
• Work with both ECT and private providers to facilitate additional activity
• Revisit the Kings Fund 2010 referral management recommendations
5. Recommendation regarding level of risk
• Approve the increased re-grading of the risk in to a Risk Score of at least
16 (Likelihood 4 x Impact 4) as a consequence of the CCG being unable to
meet its statutory duty to provide patients with timely access to treatment
under the NHS Constitution
• Endorse the actions suggested in order to support the reduction of the risk
level in the near future